Agricultural Biologicals Market Growth & TrendsThe global agricultural biologicals market size is expected to reach USD 16.8 billion by 2030, registering a CAGR of 7.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rising deman…
The global market for agricultural biologicals is estimated at USD 16.7 billion in 2024 and is projected to reach USD 31.8 billion by 2029, at a CAGR of 13.8% during the forecast period. According to FiBL & IFOAM – Organics International, organic farming …
Global Plant Based Biomanufacturing Market, By Product Type (Antibodies, Vaccines, Proteins, Biologics, Enzyme, Others), By Technology (Upstream v/s Downstream) By Source (Whole Plant, Plant Cells, Seed, Leaf, Others), By End User (Biotechnology & Pharmaceutical Companies, Contract Manufacturing Organizations, Others), By Region, Competition Forecast & Opportunities, 2026
Global plant based biomanufacturing market will report an impressive CAGR in the forecast period, 2022-2026. The market growth can be attributed to the advancing healthcare capabilities to device treatment from plant based elements. Moreover, increasing n…
As the global economy mends, the 2021 growth of Biologics Contract Manufacturing will have significant change from previous year. According to our (LP Information) latest study, the global Biologics Contract Manufacturing market size is USD million in 202…
The global biologics market reached a value of US$ 294 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 501.9 Billion by 2027, exhibiting a CAGR of 9.25% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are …
Biologics Contract Manufacturing Market – Scope of ReportTMR’s report on the global biologics contract manufacturing market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market d…
Regulatory Affairs Outsourcing Market Size, Share & Trends Analysis Report By Category (Biologics, Medical Devices), By Company Size (Medium, Large), By Indication, By Stage, By Services, By End Use, And Segment Forecasts, 2022 - 2030
Regulatory Affairs Outsourcing Market Growth & TrendsThe global regulatory affairs outsourcing market size is expected to reach USD 13.9 billion by 2030, registering a CAGR of 8.9% over the forecast period, according to a new report by Grand View Research…
Global Biologics CDMO Market 2022-2026Technavio has been monitoring the biologics CDMO market and it is poised to grow by $ 8.65 bn during 2022-2026, progressing at a CAGR of 12.20% during the forecast period. Our report on the biologics CDMO market provi…
The global biologics market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 9% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the …
The biologics used in Anti-inflammatory treatment – abatacept (Orencia), adalimumab (Humira), anakinra (Kineret), etanercept (Enbrel), infliximab (Remicade) and rituximab (Rituxan) – block triggers of inflammation. Biologics may be used alone or in combin…
Global Cancer Biologics Market Status, Trends and COVID-19 Impact Report 2021 Single User License Report: 2350 USD Corporate User License Report: 4700 USD Section Price: As below In the past few years, the Cancer Biologics market experienced a huge chang…
Pharmaceutical Contract Development and Manufacturing Market (Pharmaceutical, Biologics, Active Pharma ingredients, tablet, Parenteral, Oral Liquid, Semi-Solids), End User (Big Pharma, Small Pharma, Generic Pharma, CRO)-Global Forecast to 2026
The global pharmaceutical contract development and manufacturing market is projected to reach USD 171.3 billion by 2026 from USD 120.6 billion in 2021, at a CAGR of 7.3% during the forecast period. Market growth is driven mainly by factors such as rising …
Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Status, Trends and COVID-19 Impact Report 2021Single User License Report: 2350 USDCorporate User License Report: 4700 USDSection Price: As belowPage: 115Chart and Figure: 1…
Global Ulcerative Colitis Market by Drug Type (Anti-Inflammatory Drugs, Anti-TNF biologics, Immunosuppressant, Calcineurin Inhibitors, and Other Drug Types), Disease Type (Ulcerative Proctitis, Proctosigmoiditis, Left-sided Colitis, Pancolitis or Universal Colitis, and Fulminant Colitis), Regional Forecasts 2021-2027
Global Ulcerative Colitis Market is valued approximately at USD XX billion in 2020 and is anticipated to grow with a healthy growth rate of more than 5.3% over the forecast period 2021-2027. Ulcerative colitis (UCs) is a chronic, inflammatory condition af…
The Global Biologics CDMO Market was valued at USD 9.93 billion in 2020 and is expected to reach USD 18.63 billion by 2026, registering a CAGR of 10.87% during the forecast period (2021-2026).The CMO/CDMO service sector is uniquely positioned to address s…
Regulatory Affairs Market Size, Share & Trends Analysis Report By Service, By Categories (Biologics, Drugs), By Indication, By Product Stage, By End Use, By Service Providers, By Company Size, By Region, And Segment Forecasts, 2021 - 2028
Regulatory Affairs Market Growth & TrendsThe global regulatory affairs market size is expected to reach USD 22.7 billion by 2028 registering a CAGR of 8.4%, according to a new report by Grand View Research, Inc. Rise in drug approvals, label expansions of…